IDEAS home Printed from https://ideas.repec.org/r/eee/hepoli/v109y2013i3p253-262.html
   My bibliography  Save this item

The new risk adjustment formula in Germany: Implementation and first experiences

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Bauhoff, Sebastian & Fischer, Lisa & Göpffarth, Dirk & Wuppermann, Amelie C., 2017. "Plan responses to diagnosis-based payment: Evidence from Germany’s morbidity-based risk adjustment," Journal of Health Economics, Elsevier, vol. 56(C), pages 397-413.
  2. Pilny, Adam & Wübker, Ansgar & Ziebarth, Nicolas R., 2017. "Introducing risk adjustment and free health plan choice in employer-based health insurance: Evidence from Germany," Journal of Health Economics, Elsevier, vol. 56(C), pages 330-351.
  3. Göpffarth, Dirk & Henke, Klaus-Dirk, 2013. "The German Central Health Fund—Recent developments in health care financing in Germany," Health Policy, Elsevier, vol. 109(3), pages 246-252.
  4. Schmid, Christian P.R. & Beck, Konstantin, 2016. "Re-insurance in the Swiss health insurance market: Fit, power, and balance," Health Policy, Elsevier, vol. 120(7), pages 848-855.
  5. Florian Buchner & Jürgen Wasem & Sonja Schillo, 2017. "Regression Trees Identify Relevant Interactions: Can This Improve the Predictive Performance of Risk Adjustment?," Health Economics, John Wiley & Sons, Ltd., vol. 26(1), pages 74-85, January.
  6. Amir Shmueli, 2015. "On the calculation of the Israeli risk adjustment rates," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(3), pages 271-277, April.
  7. Conor Keegan & Conor Teljeur & Brian Turner & Steve Thomas, 2017. "Addressing Market Segmentation and Incentives for Risk Selection: How Well Does Risk Equalisation in the Irish Private Health Insurance Market Work?," The Economic and Social Review, Economic and Social Studies, vol. 48(1), pages 61-84.
  8. Schang, Laura & Thomson, Sarah & Czypionka, Thomas, 2016. "Explaining differences in stakeholder take up of disease management programmes: A comparative analysis of policy implementation in Austria and Germany," Health Policy, Elsevier, vol. 120(3), pages 281-292.
  9. Pili Ferrer & Elena Ballarín & Mònica Sabaté & Joan-Ramon Laporte & Marieke Schoonen & Marietta Rottenkolber & Joan Fortuny & Joerg Hasford & Iain Tatt & Luisa Ibáñez, 2014. "Sources of European drug consumption data at a country level," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 59(5), pages 877-887, October.
  10. Thomson, Sarah & Busse, Reinhard & Crivelli, Luca & van de Ven, Wynand & Van de Voorde, Carine, 2013. "Statutory health insurance competition in Europe: A four-country comparison," Health Policy, Elsevier, vol. 109(3), pages 209-225.
  11. Keith M. Marzilli Ericson & Kimberley H. Geissler & Benjamin Lubin, 2018. "The Impact of Partial-Year Enrollment on the Accuracy of Risk-Adjustment Systems: A Framework and Evidence," American Journal of Health Economics, MIT Press, vol. 4(4), pages 454-478, Fall.
  12. Withagen-Koster, Anja A. & van Kleef, Richard C. & Eijkenaar, Frank, 2023. "Predictable profits and losses in a health insurance market with risk equalization: A multiple-contract period perspective," Health Policy, Elsevier, vol. 131(C).
  13. Schillo, Sonja & Lux, Gerald & Wasem, Juergen & Buchner, Florian, 2016. "High cost pool or high cost groups—How to handle high(est) cost cases in a risk adjustment mechanism?," Health Policy, Elsevier, vol. 120(2), pages 141-147.
  14. Camilo Cid & Randall P. Ellis & Verónica Vargas & Juergen Wasem & Lorena Prieto, 2015. "Global Risk-Adjusted Payment Models," Boston University - Department of Economics - Working Papers Series wp2015-021, Boston University - Department of Economics.
  15. van den Broek-Altenburg, Eline M. & Atherly, Adam J., 2020. "The relation between selective contracting and healthcare expenditures in private health insurance plans in the United States," Health Policy, Elsevier, vol. 124(2), pages 174-182.
  16. Florian Kirsch & Christian Becker & Anja Schramm & Werner Maier & Reiner Leidl, 2020. "Patients with coronary artery disease after acute myocardial infarction: effects of continuous enrollment in a structured Disease Management Program on adherence to guideline-recommended medication, h," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(4), pages 607-619, June.
  17. Julie Shi & Yi Yao & Gordon Liu, 2018. "Modeling individual health care expenditures in China: Evidence to assist payment reform in public insurance," Health Economics, John Wiley & Sons, Ltd., vol. 27(12), pages 1945-1962, December.
  18. Karmann Alexander & Weinhold Ines & Wende Danny, 2019. "Area Deprivation and its Impact on Population Health: Conceptual Aspects, Measurement and Evidence from Germany," Review of Economics, De Gruyter, vol. 70(1), pages 69-98, April.
  19. Jonas B. Pendzialek & Dusan Simic & Stephanie Stock, 2017. "Measuring customer preferences in the German statutory health insurance," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(7), pages 831-845, September.
  20. Wasem, Jürgen & Buchner, Florian & Lux, Gerald & Schillo, Sonja, 2017. "High Cost Pool in a Health Status Based Risk Adjustment System – Some Conceptional and Empirical Considerations," VfS Annual Conference 2017 (Vienna): Alternative Structures for Money and Banking 168122, Verein für Socialpolitik / German Economic Association.
  21. K. P. M. Winssen & R. C. Kleef & W. P. M. M. Ven, 2017. "A voluntary deductible in health insurance: the more years you opt for it, the lower your premium?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(2), pages 209-226, March.
  22. Frank Eijkenaar & René C. J. A. Vliet, 2018. "Improving risk equalization using information on physiotherapy diagnoses," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(2), pages 203-211, March.
  23. Ines Weinhold & Christian Schindler & Nils Kossack & Benjamin Berndt & Dennis Häckl, 2019. "Economic impact of disease prevention in a morbidity-based financing system: does prevention pay off for a statutory health insurance fund in Germany?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(8), pages 1181-1193, November.
  24. Eijkenaar, Frank & van Vliet, René C.J.A., 2017. "Improving risk equalization for individuals with persistently high costs: Experiences from the Netherlands," Health Policy, Elsevier, vol. 121(11), pages 1169-1176.
  25. Richard C. Kleef & Mieke Reuser, 2021. "How the COVID-19 pandemic can distort risk adjustment of health plan payment," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(7), pages 1005-1016, September.
  26. van Kleef, R.C. & van Vliet, R.C.J.A. & van Rooijen, E.M., 2014. "Diagnoses-based cost groups in the Dutch risk-equalization model: The effects of including outpatient diagnoses," Health Policy, Elsevier, vol. 115(1), pages 52-59.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.